Search Results

There are 2418 results for: content related to: Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder

  1. Escitalopram versus other antidepressive agents for depression

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Claudio Santilli, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Hugh McGuire, Rachel Churchill and Corrado Barbui

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD006532.pub2

  2. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro

    CNS Neuroscience & Therapeutics

    Ouissame Mnie-Filali, Thorsten Lau, Friederike Matthaeus, Erika Abrial, Sarah Delcourte, Mostafa El Mansari, Alan Pershon, Patrick Schloss, Connie Sánchez and Nasser Haddjeri

    Version of Record online : 12 MAY 2016, DOI: 10.1111/cns.12562

  3. You have free access to this content
    Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice

    British Journal of Pharmacology

    Volume 168, Issue 1, January 2013, Pages: 103–116, Hai T Nguyen, Bruno P Guiard, Alexandre Bacq, Denis J David, Indira David, Gaël Quesseveur, Sophie Gautron, Connie Sanchez and Alain M Gardier

    Version of Record online : 18 DEC 2012, DOI: 10.1111/j.1476-5381.2012.01850.x

  4. Impact of the Ultrarapid CYP2C19*17 Allele on Serum Concentration of Escitalopram in Psychiatric Patients

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 2, February 2008, Pages: 322–327, I Rudberg, B Mohebi, M Hermann, H Refsum and E Molden

    Version of Record online : 11 JUL 2007, DOI: 10.1038/sj.clpt.6100291

  5. You have full text access to this OnlineOpen article
    Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation

    International Journal of Clinical Practice

    Volume 61, Issue 4, April 2007, Pages: 702–710, P. M. Llorca and J.-L. Fernandez

    Version of Record online : 22 MAR 2007, DOI: 10.1111/j.1742-1241.2007.01335.x

  6. Efficacy of escitalopram in patients with severe depression: a pooled analysis

    International Journal of Clinical Practice

    Volume 59, Issue 3, March 2005, Pages: 268–275, P-M Llorca, J-M Azorin, N. Despiegel and P. Verpillat

    Version of Record online : 23 FEB 2005, DOI: 10.1111/j.1742-1241.2005.00440.x

  7. You have full text access to this OnlineOpen article
    Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression

    Pharmacology Research & Perspectives

    Volume 3, Issue 6, December 2015, Fionn E. O'Brien, Gerard M. Moloney, Karen A. Scott, Richard M. O'Connor, Gerard Clarke, Timothy G. Dinan, Brendan T. Griffin and John F. Cryan

    Version of Record online : 26 OCT 2015, DOI: 10.1002/prp2.190

  8. The Pharmacokinetics of Escitalopram After Oral and Intravenous Administration of Single and Multiple Doses to Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 45, Issue 12, December 2005, Pages: 1400–1406, B. Søgaard, H. Mengel, N. Rao and F. Larsen

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270005280860

  9. Escitalopram Is a Weak Inhibitor of the CYP2D6-Catalyzed O-Demethylation of (+)-Tramadol but Does Not Reduce the Hypoalgesic Effect in Experimental Pain

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 6, December 2009, Pages: 626–633, L Noehr-Jensen, S T Zwisler, F Larsen, S H Sindrup, P Damkier and K Brosen

    Version of Record online : 26 AUG 2009, DOI: 10.1038/clpt.2009.154

  10. Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat

    Synapse

    Volume 65, Issue 5, May 2011, Pages: 357–367, Björn Schilström, Åsa Konradsson-Geuken, Vladimir Ivanov, Jens Gertow, Kristin Feltmann, Monica M. Marcus, Kent Jardemark and Torgny H. Svensson

    Version of Record online : 24 SEP 2010, DOI: 10.1002/syn.20853

  11. You have free access to this content
    Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 11-12, December 2011, Pages: 1306–1317, R. J. de Knegt, G. Bezemer, A. R. Van Gool, J. P. H. Drenth, B. E. Hansen, H. A. Droogleever Fortuyn, C. J. Weegink, M. W. Hengeveld and H. L. A. Janssen

    Version of Record online : 17 OCT 2011, DOI: 10.1111/j.1365-2036.2011.04867.x

    Corrected by:

    CORRIGENDA: Corrigenda

    Vol. 35, Issue 7, 864, Version of Record online: 8 MAR 2012

  12. You have free access to this content
    Citalopram versus other anti-depressive agents for depression

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Marianna Purgato, Toshi A Furukawa, Carlotta Trespidi, Giuseppe Imperadore, Alessandra Signoretti, Rachel Churchill, Norio Watanabe and Corrado Barbui

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD006534.pub2

  13. You have free access to this content
    The Role of the Two-Pore Domain Potassium Channel TREK-1 in the Therapeutic Effects of Escitalopram in a Rat Model of Poststroke Depression

    CNS Neuroscience & Therapeutics

    Volume 21, Issue 6, June 2015, Pages: 504–512, Dai-Hua Lin, Xiang-Rong Zhang, Dong-Qing Ye, Guang-Jun Xi, Jiao-Jie Hui, Shan-Shan Liu, Lin-Jiang Li and Zhi-Jun Zhang

    Version of Record online : 10 FEB 2015, DOI: 10.1111/cns.12384

  14. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction

    The Journal of Sexual Medicine

    Volume 12, Issue 10, October 2015, Pages: 2036–2048, Paula L. Jacobsen, Atul R. Mahableshwarkar, Yinzhong Chen, Lambros Chrones and Anita H. Clayton

    Version of Record online : 31 AUG 2015, DOI: 10.1111/jsm.12980

  15. Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: Behavioral, biochemical, and electrophysiological evidence

    Synapse

    Volume 66, Issue 4, April 2012, Pages: 277–290, Monica M. Marcus, Kent Jardemark, Anna Malmerfelt, Jens Gertow, Åsa Konradsson-Geuken and Torgny H. Svensson

    Version of Record online : 13 DEC 2011, DOI: 10.1002/syn.21510

  16. You have free access to this content
    The effect of cimetidine or omeprazole on the pharmacokinetics of escitalopram in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 60, Issue 3, September 2005, Pages: 287–290, D. Malling, M. N. Poulsen and B. Søgaard

    Version of Record online : 29 JUN 2005, DOI: 10.1111/j.1365-2125.2005.02423.x

  17. Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors

    European Journal of Cancer Care

    N. Biglia, V.E. Bounous, T. Susini, S. Pecchio, L.G. Sgro, V. Tuninetti and R. Torta

    Version of Record online : 3 MAR 2016, DOI: 10.1111/ecc.12484

  18. Molecular Dynamics Simulations of Na+/Cl-Dependent Neurotransmitter Transporters in a Membrane-Aqueous System

    ChemMedChem

    Volume 2, Issue 6, June 11, 2007, Pages: 827–840, Anne Marie Jørgensen, Lena Tagmose, Anne Marie M. Jørgensen, Klaus P. Bøgesø and Günther H. Peters

    Version of Record online : 13 APR 2007, DOI: 10.1002/cmdc.200600243

  19. You have free access to this content
    Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk

    British Journal of Clinical Pharmacology

    Volume 62, Issue 3, September 2006, Pages: 316–322, Jonathan Rampono, L. Peter Hackett, Judith H. Kristensen, Rolland Kohan, Madhu Page-Sharp and Kenneth F. Ilett

    Version of Record online : 21 APR 2006, DOI: 10.1111/j.1365-2125.2006.02659.x

  20. Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure

    The Journal of Clinical Pharmacology

    Volume 50, Issue 1, January 2010, Pages: 62–72, Ms Yuyan Jin, Dr Bruce G. Pollock, Dr Ellen Frank, Dr Giovanni B. Cassano, Dr Paola Rucci, Dr Daniel J. Müller, Dr James L. Kennedy, Dr Rocco Nicola Forgione, Ms Margaret Kirshner, Ms Gail Kepple, Dr Andrea Fagiolini, David J. Kupfer and Dr Robert R. Bies

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009337946